Log In
BCIQ
Print this Print this
 

Afstyla (rVIII-SingleChain) (CSL627) (formerly rFVIII)

  Manage Alerts
Collapse Summary General Information
Company CSL Ltd.
DescriptionRecombinant coagulation single-chain Factor VIII (rFVIII)
Molecular Target Factor VIII
Mechanism of ActionEnzyme replacement therapy
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentApproved
Standard IndicationHemophilia
Indication DetailsTreat hemophilia A; Treat hemophilia A in pediatric patients
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today